Page last updated: 2024-10-16

carnitine and Myeloproliferative Disorders

carnitine has been researched along with Myeloproliferative Disorders in 1 studies

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research Excerpts

ExcerptRelevanceReference
"Irradiation significantly increased oral mucositis, and decreased thrombocyte and White Blood Cell counts."1.33Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced oral mucositis and myelosuppression: a controlled study in a rat model. ( Erdoğan, F; Ertekin, MV; Gündoğdu, C; Kiziltunç, A; Ozkan, A; Sezen, O; Uçüncü, H; Yörük, O, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uçüncü, H1
Ertekin, MV1
Yörük, O1
Sezen, O1
Ozkan, A1
Erdoğan, F1
Kiziltunç, A1
Gündoğdu, C1

Other Studies

1 other study available for carnitine and Myeloproliferative Disorders

ArticleYear
Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced oral mucositis and myelosuppression: a controlled study in a rat model.
    Journal of radiation research, 2006, Volume: 47, Issue:1

    Topics: Administration, Oral; Animals; Carnitine; Dietary Supplements; Disease Models, Animal; Drug Combinat

2006